Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-01-15 @ 2:48 AM
Study NCT ID:
NCT00326495
Status:
COMPLETED
Last Update Posted:
2017-07-24
First Post:
2006-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
060164
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None